U.S. Department of Energy

Pacific Northwest National Laboratory

You are here

Home › Presentations › Application of an antibody-independent, highly sensitive PRISM-SRM proteomics approach for monitoring TMPRSS2-ERG fusion proteins in prostate cancer cell lines and tumor tissues

Application of an antibody-independent, highly sensitive PRISM-SRM proteomics approach for monitoring TMPRSS2-ERG fusion proteins in prostate cancer cell lines and tumor tissues

Powered by Drupal
| Pacific Northwest National Laboratory